Current Fungal Infection Reports

ISSN: 1936-3761

Journal Home

Journal Guideline

Current Fungal Infection Reports Q3 Unclaimed

Current Science, Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Fungal Infection Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of fungal infection. It has an SJR impact factor of 0,315.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Infectious Diseases (Q3)
Price

2490 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Current Fungal Infection Reports

0,315

SJR Impact factor

31

H Index

29

Total Docs (Last Year)

81

Total Docs (3 years)

2132

Total Refs

141

Total Cites (3 years)

81

Citable Docs (3 years)

2.56

Cites/Doc (2 years)

73.52

Ref/Doc

Comments

No comments ... Be the first to comment!

Other journals with similar parameters


Acta Botanica Brasilica Q3
Grana Q3
Candollea Q3
Chinese Journal of Plant Ecology Q3
Turczaninowia Q3

Compare this journals

Aims and Scope





Best articles by citations

Safety and Efficacy Data for High-Dose Caspofungin

View more

Progress Toward a Human Vaccine Against Coccidioidomycosis

View more

Coccidioidomycosis

View more

Genetic factors associated with susceptibility to invasive aspergillosis

View more

Fungal taxonomy: New developments in medically important fungi

View more

The Growing Role of Clinical and Genomic Databases in the Development of Antifungal Strategies

View more

Therapeutic Drug Monitoring of Posaconazole: an Update

View more

Epidemiology of Endemic Mycosis in Children

View more

Echinocandin Dosing in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

View more

Echinocandins for Primary Therapy of Candidemia: Time for a Paradigm Shift?

View more

Definitions and Epidemiology of Candida Species not Susceptible to Echinocandins

View more

The Airway Colonization by Opportunistic Filamentous Fungi in Patients with Cystic Fibrosis: Recent Updates

View more
SHOW MORE ARTICLES

Current Status in Diagnosis of Scedosporium Infections: What Is the Impact of New Molecular Methods?

View more

Fungi in Cystic Fibrosis: Recent Findings and Unresolved Questions

View more

Diagnosis and treatment of allergic bronchopulmonary aspergillosis

View more

Pityriasis Versicolor in Children and Adolescents: an Update

View more

Pityriasis Versicolor: Clinical Spectrum and Diagnosis

View more

Early diagnosis of blood culture isolates in patients with candidemia using PNA FISH

View more

Cryptococcal Antigen Screening and Treatment: The Current State of Global Screening Programs to Prevent Death from Cryptococcal Infection

View more

Antifungal Dose Adjustment in Renal and Hepatic Dysfunction: Pharmacokinetic and Pharmacodynamic Considerations

View more

Antifungal Dosing in Critically Ill Patients

View more

Antifungal Dosing in Dialysis and Continuous Renal Replacement Therapy

View more

Antifungal Dosing in Obesity: A Review of the Literature

View more

Epidemiology of Invasive Fungal Infections in Latin America

View more

FAQS